Cancers Clinical Trials in Toronto, Ontario
11 recruitingToronto, Ontario, Canada
Showing 1–11 of 11 trials
Recruiting
Phase 2
Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)
Pancreatic Neuroendocrine TumorVon Hippel-Lindau DiseasePheochromocytoma/Paraganglioma+2 more
Merck Sharp & Dohme LLC355 enrolled84 locationsNCT04924075
Recruiting
Phase 1Phase 2
BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours
Gastric CancersColorectal, CancerPancreatic Cancer+1 more
Bold Therapeutics, Inc.220 enrolled24 locationsNCT04421820
Recruiting
Phase 1Phase 2
A Study of REC-1245 in Participants With Unresectable, Locally Advanced, or Metastatic Cancer
Locally AdvancedUnresectableMetastatic Cancers+1 more
Recursion Pharmaceuticals Inc.170 enrolled6 locationsNCT06678659
Recruiting
Not Applicable
Mainstreaming Genetics: Evaluation of a Digital Application to Scale and Spread Oncologist-initiated Genetic Testing
Breast CancerPancreatic CancerOvarian Cancer+4 more
Unity Health Toronto180 enrolled2 locationsNCT07387263
Recruiting
Phase 1
A Study Evaluating Single-agent Inavolisib, Inavolisib Plus Atezolizumab, and Inavolisib Plus Pembrolizumab in PIK3CA-Mutated Cancers
PIK3CA-Mutated Cancers
Hoffmann-La Roche30 enrolled8 locationsNCT06496568
Recruiting
Phase 1
A Study Evaluating Anvumetostat in Combination With Other Therapies in Participants With Advanced Gastrointestinal, Biliary Tract, or Pancreatic Cancers With Homozygous Methylthioadenosine Phosphorylase (MTAP)-Deletion (MTAPESTRY 103)
Advanced Gastrointestinal, Biliary Tract, and Pancreatic Cancers
Amgen350 enrolled77 locationsNCT06360354
Recruiting
Phase 2
Stereotactic Radiotherapy (SBRT) of Lung Metastasis
Non-small Cell Lung CancerMetastasis From Other Cancers
University Health Network, Toronto200 enrolled1 locationNCT01803542
Recruiting
Phase 1
Study to Assess the Safety and Effects of Porphysome Nanoparticles for Imaging in Gynaecological Cancers
Gynecological Cancers
University Health Network, Toronto24 enrolled1 locationNCT06977126
Recruiting
Not Applicable
Sustainable Implementation of the EXCEL Exercise Oncology Program Across Canada
Lung CancersCancerColon Cancer+2 more
University of Calgary740 enrolled5 locationsNCT06960291
Recruiting
Phase 2
Combined Gamma Knife/Linac Radiosurgery for Large Brain Tumors / Metastases
Brain MetastasasesBrain (Nervous System) CancersSRS
Sunnybrook Health Sciences Centre60 enrolled1 locationNCT07162246
Recruiting
Phase 1Phase 2
A Beta-only IL-2 ImmunoTherapY Study
Triple-Negative Breast CancerEsophageal CancerGastric Cancer+34 more
Medicenna Therapeutics, Inc.115 enrolled27 locationsNCT05086692